Matches in SemOpenAlex for { <https://semopenalex.org/work/W2474761603> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2474761603 endingPage "54" @default.
- W2474761603 startingPage "849" @default.
- W2474761603 abstract "The efficacy of combined high-dose etoposide with standard dose cisplatin was evaluated in patients who had refractory lung cancer after standard chemotherapy. Each patient was given etoposide at 500 mg/m2/day on day 1 to 3 continuously (total dose 1,500 mg/m2) and cisplatin at 80 mg/m2 on day 1. Fifteen patients (7 adenocarcinoma, 5 small cell lung cancer, 2 squamous cell lung cancer and 1 sarcoma, which latter was difficult to distinguish from giant cell carcinoma) were entered in this study. The overall response was 41.7% (5 of 12); five partial response, 6 no change, and 1 progressive disease. Three treatment-related deaths were observed; one resulted from sepsis and two from respiratory failure because of tumor progression. All of the patients developed severe myelosuppression; the mean nadir white blood cell count was 400, and the mean nadir platelet count was 24,000 in 28 evaluable courses. The range of maximum concentration of etoposide determined by HPLC was from 17.4 to 39.1 micrograms/ml. These results suggest that high-dose etoposide combined with a standard dose of cisplatin is effective against refractory lung cancer." @default.
- W2474761603 created "2016-07-22" @default.
- W2474761603 creator A5015685384 @default.
- W2474761603 creator A5017426381 @default.
- W2474761603 creator A5039435551 @default.
- W2474761603 creator A5041793872 @default.
- W2474761603 creator A5047110554 @default.
- W2474761603 creator A5049499000 @default.
- W2474761603 creator A5060216202 @default.
- W2474761603 creator A5069582094 @default.
- W2474761603 creator A5074011496 @default.
- W2474761603 creator A5087503433 @default.
- W2474761603 date "1992-06-01" @default.
- W2474761603 modified "2023-09-23" @default.
- W2474761603 title "[Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer]." @default.
- W2474761603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1318697" @default.
- W2474761603 hasPublicationYear "1992" @default.
- W2474761603 type Work @default.
- W2474761603 sameAs 2474761603 @default.
- W2474761603 citedByCount "0" @default.
- W2474761603 crossrefType "journal-article" @default.
- W2474761603 hasAuthorship W2474761603A5015685384 @default.
- W2474761603 hasAuthorship W2474761603A5017426381 @default.
- W2474761603 hasAuthorship W2474761603A5039435551 @default.
- W2474761603 hasAuthorship W2474761603A5041793872 @default.
- W2474761603 hasAuthorship W2474761603A5047110554 @default.
- W2474761603 hasAuthorship W2474761603A5049499000 @default.
- W2474761603 hasAuthorship W2474761603A5060216202 @default.
- W2474761603 hasAuthorship W2474761603A5069582094 @default.
- W2474761603 hasAuthorship W2474761603A5074011496 @default.
- W2474761603 hasAuthorship W2474761603A5087503433 @default.
- W2474761603 hasConcept C121608353 @default.
- W2474761603 hasConcept C126322002 @default.
- W2474761603 hasConcept C126894567 @default.
- W2474761603 hasConcept C142424586 @default.
- W2474761603 hasConcept C143998085 @default.
- W2474761603 hasConcept C2776256026 @default.
- W2474761603 hasConcept C2776694085 @default.
- W2474761603 hasConcept C2778119113 @default.
- W2474761603 hasConcept C2778239845 @default.
- W2474761603 hasConcept C2781182431 @default.
- W2474761603 hasConcept C71924100 @default.
- W2474761603 hasConcept C86803240 @default.
- W2474761603 hasConcept C87355193 @default.
- W2474761603 hasConcept C90924648 @default.
- W2474761603 hasConceptScore W2474761603C121608353 @default.
- W2474761603 hasConceptScore W2474761603C126322002 @default.
- W2474761603 hasConceptScore W2474761603C126894567 @default.
- W2474761603 hasConceptScore W2474761603C142424586 @default.
- W2474761603 hasConceptScore W2474761603C143998085 @default.
- W2474761603 hasConceptScore W2474761603C2776256026 @default.
- W2474761603 hasConceptScore W2474761603C2776694085 @default.
- W2474761603 hasConceptScore W2474761603C2778119113 @default.
- W2474761603 hasConceptScore W2474761603C2778239845 @default.
- W2474761603 hasConceptScore W2474761603C2781182431 @default.
- W2474761603 hasConceptScore W2474761603C71924100 @default.
- W2474761603 hasConceptScore W2474761603C86803240 @default.
- W2474761603 hasConceptScore W2474761603C87355193 @default.
- W2474761603 hasConceptScore W2474761603C90924648 @default.
- W2474761603 hasIssue "6" @default.
- W2474761603 hasLocation W24747616031 @default.
- W2474761603 hasOpenAccess W2474761603 @default.
- W2474761603 hasPrimaryLocation W24747616031 @default.
- W2474761603 hasRelatedWork W2083033314 @default.
- W2474761603 hasRelatedWork W2124411053 @default.
- W2474761603 hasRelatedWork W2314517044 @default.
- W2474761603 hasRelatedWork W2358156577 @default.
- W2474761603 hasRelatedWork W2378830451 @default.
- W2474761603 hasRelatedWork W2381460883 @default.
- W2474761603 hasRelatedWork W2402653143 @default.
- W2474761603 hasRelatedWork W363598932 @default.
- W2474761603 hasRelatedWork W4214942838 @default.
- W2474761603 hasRelatedWork W8414141 @default.
- W2474761603 hasVolume "19" @default.
- W2474761603 isParatext "false" @default.
- W2474761603 isRetracted "false" @default.
- W2474761603 magId "2474761603" @default.
- W2474761603 workType "article" @default.